FindTrial
Sign In

The effecacy of continunous and intermittent inhalation of glucocoticoids on the stature growth of recurrent wheezing infants

The effecacy of continunous and intermittent inhalation of glucocoticoids on the stature growth of recurrent wheezing infants

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-17013703
Enrollment
Unknown
Registered
2017-12-05
Start date
2017-12-11
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

Two groups:continunous verus intermittent inhalation of glucocoticoids

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 3 Years

Inclusion criteria

Inclusion criteria: 1. children aged 1-3 years with both API positive and recurrent wheezing; 2. at least 2 acute wheezing attacks within the year; 3. allowed 1-2 times of systemic glucocoticoid recieving during the research.

Exclusion criteria

Exclusion criteria: 1. a long-term recieving glucocoticoid; 2. deviation in growth and development; 3. diseases in important organs.

Design outcomes

Primary

MeasureTime frame
weight;height;—

Contacts

Public ContactYing Huang

Children's Hospital of Chongqing Medical University

huangying62@126.com+86 13677673800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026